Načítá se...
Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits
This study investigated whether PRM–151 (Promedior, Inc., Malvern, PA), a recombinant form of human pentraxin-2 (PTX-2, also referred to as serum amyloid P, hSAP), that inhibits differentiation of circulating monocytes into fibrocytes and profibrotic macrophages, could modulate generation of myofibr...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3221812/ https://ncbi.nlm.nih.gov/pubmed/21933674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exer.2011.08.015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|